PCU Shift Lead MWS cPB89

优缺点分析

角色解读

• Next step could be Global TA Head or VP of a therapeutic area.
• Opportunity to lead larger portfolio or franchise within Sanofi.
• Potential transition to C-suite roles (e.g., CCO, CEO of a business unit) with demonstrated success.
• Develop and execute global brand strategy for Ayvakit, a rare disease drug.
• Lead a cross-functional global brand team comprising commercial, medical, regulatory, and supply chain leaders.
• Drive launch readiness and commercialization for new markets outside the US.
• Manage financial performance including revenue, market share, and budget.
• Proven leadership in global marketing and launch, especially in rare diseases.
• Strategic agility and ability to navigate complex access and pricing environments.
• Strong cross-functional collaboration and executive communication skills.
• Deep understanding of classic marketing disciplines and data-driven decision-making.

申请策略

• Tailor cover letter to demonstrate alignment with Sanofi's mission and launch excellence strategy.
• Prepare to discuss specific examples of building brands from phase to blockbuster.
• Emphasize 15+ years of progressive experience in marketing and general management with global scope.
• Quantify achievements in brand launches, revenue growth, and market share gains.
• Highlight leadership of cross-functional teams and experience in rare disease or specialty care.
• Showcase ability to navigate pricing, access, and regulatory challenges.
• Deepen understanding of AI and data analytics in pharma marketing.
• Familiarize with Sanofi's rare disease portfolio and competitive landscape.

面试指南

• Use STAR method: Situation, Task, Action, Result.
• Focus on strategic thinking, collaboration, and results orientation.
• Include specific metrics and outcomes to demonstrate impact.
• How would you develop a global launch strategy for Ayvakit in a new market?
• Describe a time you led a cross-functional team through a challenging launch.
• How do you balance short-term revenue targets with long-term brand equity?
• What is your approach to pricing and market access for a rare disease drug?
• How have you used data and AI to drive marketing decisions?